Promising results provide hope for humans suffering from chronic paralysis
Millions of people worldwide are living with chronic spinal cord injuries, with 250,000 to 500,000 new cases each year—most from vehicle crashes or falls. The most severe spinal cord injuries completely paralyze their victims and more than half impair a person’s ability to breathe. Now, a breakthrough study published in Nature Communications has demonstrated, in animal models of chronic injury, that long-term, devastating effects of spinal cord trauma on breathing and limb function may be reversible.
The new study describes a treatment regimen that helps reawaken certain special types of nerve cells that can regenerate extensions, called axons, within the damaged spinal cord. Rats with spinal cords half severed at the second cervical vertebrae (C2) regained complete diaphragm and partial forelimb function on the severed side after treatment. The recuperative effects of the therapy were fully maintained six months after treatment end.
“For the first time we have permanently restored both breathing and some arm function in a form of high cervical, chronic spinal cord injury-induced paralysis. The complete recovery, especially of breathing, occurs rapidly after a near lifetime of paralysis in a rodent model,” says senior author Jerry Silver, PhD, professor of neurosciences at Case Western Reserve University School of Medicine.
The treatment leverages the body’s innate ability to very slowly sprout new axon branches from a sub-population of nerve cells that remain intact below the injury. The activity of these new branches is completely stifled by a family of potently inhibitory molecules called proteoglycans. Said Silver, “The strategy was to use a simple, one-time injection of an enzyme, chondroitinase, that breaks down the inhibitory proteoglycan molecules. The enzyme was administered, not within the lesion itself, but lower down within the spinal cord where motor nerve cells reside that send axons out to the diaphragm and forearm.”
In animals treated immediately after spinal cord injury, the enzyme only marginally helped restore nerve growth with minimal functional recovery. However, in animals treated long after injury, the therapeutic effects of the enzyme were remarkably better. In as little as one week after treatment in chronically injured rats, new nerve extensions began to restore diaphragm function that had been silent for many months. Seventy percent of rats treated with the enzyme chronically, also began to use their forelimbs to move about and explore their environment (compared to only 30 percent of control animals).
“Surprisingly, the technique worked far better at chronic stages than at acute stages after injury,” says Silver. The longer the animals had been paralyzed, the greater were the restorative effects of the enzyme. Silver’s team found that even after an unprecedented year and a half following spinal cord injury, the treatment could recover full activity to rat diaphragms. One week after treatment, 60 percent of the animals had improved diaphragm function. Two weeks later, every rat showed improvement—even though their paralysis had lasted most of their lives.
Interestingly, exposing the rats to brief periods of low oxygen levels, a respiratory therapy known as acute intermittent hypoxia, helped strengthen the growing nerve extensions, providing an added benefit. However, Silver’s team found that when the rats were treated with the enzyme combined with excessive amounts of respiratory therapy, rats developed chaotic activity in their once paralyzed diaphragms. The researchers hypothesized that the potential for highly abnormal activity may be why the body releases inhibitory molecules to prevent functional axon regeneration in the spinal cord. They are now working to optimize the combination therapy to maximize recovery, especially in the forearm and paw.
“Our data illustrate the relative ease with which an essential motor system can regain functionality months to years after severe spinal cord injury,” says Silver. “The treatment regimen in our study is relevant to multiple types of chronic incomplete spinal traumas, and we are hopeful it may also help restore motor function following spinal cord injury in humans.”
The Latest on: Spinal cord injury
via Google News
The Latest on: Spinal cord injury
- NervGen Pharma to Collaborate on Chronic Spinal Cord Injury Study Sponsored by the State of Ohioon June 22, 2020 at 6:30 pm
Ohio Department of Higher Education Awards $250,000 Grant To Dr. Jerry Silver, Co-inventor of NervGen's Lead Compound Vancouver, British Columbia--(Newsfile Corp. - June 22, 2020) - NervGen Pharma ...
- Ohio awards grant to CWRU researcher for preclinical studies in spinal cord injuryon June 22, 2020 at 7:16 am
The Ohio Department of Higher Education has awarded Jerry Silver of Case Western Reserve University a research grant to conduct preclinical studies on spinal cord injury in collaboration with NervGen ...
- Ischemic damage may play an important role in spinal cord injury during dancingon June 19, 2020 at 10:37 am
The clinical records, including injury details and radiographic data, of pediatric SCI patients (mean age, 5.97 years; age range, 4–10 years) admitted to the China Rehabilitation Research Center ...
- Taliaferro Foundation aiding spinal injury care adapts to COVID, enters 20th yearon June 15, 2020 at 5:51 pm
Penn State football player Adam Taliaferro suffered a spinal-cord injury at Ohio State that left him temporarily paralyzed and with long odds of making a recovery. The Adam Taliaferro Foundation was ...
- Asylum seeker with spinal cord injury faces eviction from his shackon June 13, 2020 at 2:04 am
Markus Nyoni has always been determined to be self-supporting. He lives in a shack and uses a wheelchair, yet he gets around on his own and earns a living. But now, because of the Covid-19 pandemic, ...
- Impact of complications at admission to rehabilitation on the functional status of patients with spinal cord lesionon June 12, 2020 at 2:42 am
Aim of the study is to evaluate the impact of complications at admission on the functional status of spinal cord lesions patie ...
- Gtx Medical receives breakthrough device designation for implanted spinal stimulation systemon June 10, 2020 at 4:22 pm
Both designations support our aim to expeditiously bring Gtx’s innovative therapies for improving functional recovery, enhancing quality of life and independence of people with spinal cord injury.” ...
- Spinal Cord Injury: Symptoms and Causeson June 9, 2020 at 5:04 am
Our Spinal Cord Injury Program specializes in caring for spinal cord injury patients immediately after the injury and during rehabilitation and recovery. We offer treatment options that are unique in ...
- GTX medical Granted FDA Breakthrough Device Designation for Go-2 Targeted Epidural Spinal Stimulation (TESS) Systemon June 9, 2020 at 2:04 am
Specifically, the device is designed to improve the reconnection of the brain with paralyzed muscles in individuals with traumatic spinal cord injury. The Company anticipates the first clinical ...
via Bing News